Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)

0.0575 0.0000 (0.00%) At close: 01:37PM EDT

Sihuan Pharmaceutical Holdings Group Ltd.

Office Tower, Convention Plaza
Room 4905 1 Harbour Road
Wan Chai
Hong Kong
852 3628 3911
https://www.sihuanpharm.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 2,872

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Fengsheng Che	Co-Founder & Executive Chairman	966.02k	N/A	1962
Dr. Weicheng Guo	Deputy Chairman & CEO	434.71k	N/A	1964
Ms. Guili Miao	Deputy CEO, Chief Investment Officer, CFO & Executive Director	420.13k	N/A	1974
Dr. Jionglong Zhang	Executive Director	102.4k	N/A	1962
Ms. Yanling Chen	Joint Company Secretary & Executive Director	228.4k	N/A	1979
Mr. Kin Wai Li	Joint Company Secretary	N/A	N/A	1989
Mr. Xianhui Meng	Deputy General Manager	588.45k	N/A	1964

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in the People's Republic of China. It offers drugs in the oncology, metabolism, diabetes, cardiovascular and cerebrovascular, modern Chinese medicine, and industrial hemp therapeutic areas. The company is also involved in the investment and sale of medical beauty products; manufacture of medical instruments; investment in properties; construction for medical projects; and project preparation for pharmaceutical products manufacturing. In addition, it provides information support, general hospital, hospital management, biotechnology and technology promotion, and medical aesthetic research and development services. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is based in Wan Chai, Hong Kong.

Corporate governance

Sihuan Pharmaceutical Holdings Group Ltd.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 6; Board: 3; Shareholder rights: 8; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.